Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07454330Not ApplicableRecruiting

Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors

Role: collaborator

NCT02946697Not ApplicableCompleted

A Culturally Sensitive Social Support Intervention

Role: collaborator

NCT03546673Not ApplicableCompleted

Health Benefits of Expressive Writing: Study One

Role: collaborator

NCT02946619Not ApplicableCompleted

Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors

Role: collaborator

All 4 trials loaded